background vaccine efficacy dose asadjuv influenza ahn rel nonadjuv child month year age multi studi conduct method total randomly assign ratio receive inject day apart acaliforniahna dose salon placebo ad group acaliforniahn nad active survey influenzalik ill continue nose throat sample obtain test use reversetranscriptas polymerase chain reaction immunogen reactogen safety ass result case confirm tandem ahnpdm infect primary analysis config inter benefit adj demons term greater observe compare concur fold antigenspar adj superior clinic import prevent increase medic attend serious adverse event data support use vaccine tandem clinic trial register not 